Sleep-wake rhythm implicated in diabetesJanuary 17th, 2009 - 1:38 pm ICT by ANI
London, Jan 17 (ANI): An international team of researchers has identified a genetic variant associated with increased fasting glucose levels and a high risk for type 2 diabetes.
The new genetic variant controls fasting glucose levels via the release of melatonin, which implicates a link between the sleep-wake rhythm.
The MTNR1B gene stalls the release of insulin via the neural hormone melatonin.
The melatonin level in the body is high at night and declines in daylight, whereas the insulin level is higher during the day than in the night, reports Nature Genetics.
This implicates an association between the sleep-wake rhythm, the so-called circadian rhythm, and fasting glucose levels.
The researchers hope that the new findings may open up new avenues for developing effective treatments, which go far beyond the primarily symptomatic therapy approaches to diabetes used today. (ANI)
- Exposure to room light before bedtime may impact sleep quality, BP - Jan 13, 2011
- A rhythm awry means rolls of fat - Aug 30, 2012
- Winter blues? Go for light therapy! - Oct 31, 2011
- Rod cells in eyes set our internal clocks - Sep 18, 2010
- Diabetes, metabolic aberrations linked with body-clock - Dec 08, 2008
- Gene behind body clock linked to increased diabetes risk - Dec 08, 2008
- Chronic drinking can disrupt body clock - Aug 25, 2010
- Pair of liver molecules could control diabetes - Apr 09, 2012
- Childhood obesity could erode fertility later - Aug 01, 2012
- In spring, extended daylight disrupts teens' sleep patterns - Jul 27, 2010
- Genetic discovery offers hope for diabetics - Jan 18, 2010
- Scientists discover better drugs for sleep problems - Apr 09, 2012
- Evolution caused genetic variation that may affect diabetes - Feb 08, 2011
- Nighttime alertness probed - Aug 27, 2009
- Poor sleep linked to worse health outcomes in diabetics - May 03, 2011
Tags: declines, diabetes, fasting glucose levels, genetic variant, high risk, hormone melatonin, insulin level, london jan, melatonin, nature genetics, neural hormone, new avenues, rhythm, sleep, symptomatic therapy, therapy approaches, type 2 diabetes